More
    Guided Solutions - Connecting Talent With Innovation/div>

    GS MedTech Funding Tracker – VentureMed, Optiscan and more

    This week in MedTech, capital is flowing into technologies that redefine intervention and precision in treatment. New funding and major deals across vascular innovation,...

    GS MedTech Funding Tracker – CoMind, Onward and more

    This week in MedTech, funding activity highlights a clear shift toward smarter, more connected care. Companies advancing brain monitoring, neuromodulation, surgical robotics, and AI-powered...

    GS MedTech Funding Tracker – HistoSonics, Adagio and more

    This week in MedTech, new investments and strategic financing are fueling the expansion of cutting-edge healthcare solutions. From histotripsy and eye care devices to...

    GS MedTech Funding Tracker – Microbot, AtaCor and more

    Innovation is gaining momentum as emerging leaders secure funding and forge strategic deals to bring next-gen solutions to market. Fresh funding and strategic deals...

    GS MedTech Funding Tracker – QT Imaging, DermaSensor and more

    EY’s new 'Pulse of the MedTech Industry' report highlights the sector is generating strong results and building confidence for the quarters ahead. This week's...

    GS MedTech Funding Tracker – Leo Cancer Care, Axon Therapies and more

    With devices that target cancer, heart failure and stroke, this week's funding is making real change in emergency healthcare settings. The Leo Cancer Care...

    GS MedTech Funding Tracker – Microbot, Nalu & more

    An interesting week for the neuromodulation field, where Nalu Medical closed $50 million growth funding. Surgical robotics is also on the uptake, with Microbot...

    GS MedTech Funding Tracker – Ronovo Surgical, Noxilizer & more

    MedTech deals this week shine a light on where innovation is heading - smarter surgery, safer sterilization, sharper diagnostics, and connected care at home....

    GS MedTech Funding Tracker – Galvanize, ViCentra & more

    The latest MedTech deals signal investor confidence in a variety of technologies, including minimally invasive diagnostics, digital insulin platforms, neuromodulation solutions, and strategic portfolio...

    Latest articles